Librería: Swan Trading Company, GEORGETOWN, TX, Estados Unidos de America
EUR 50,13
Cantidad disponible: 1 disponibles
Añadir al carritohardcover. Condición: Very Good. Hardcover shows only light cover wear. Text is unmarked and binding tight. Ships FAST!
Librería: Majestic Books, Hounslow, Reino Unido
EUR 117,53
Cantidad disponible: 3 disponibles
Añadir al carritoCondición: New.
Librería: Revaluation Books, Exeter, Reino Unido
EUR 116,06
Cantidad disponible: 2 disponibles
Añadir al carritoHardcover. Condición: Brand New. 2nd edition. 544 pages. 9.50x7.75x1.25 inches. In Stock.
Librería: Books Puddle, New York, NY, Estados Unidos de America
EUR 134,66
Cantidad disponible: 3 disponibles
Añadir al carritoCondición: New.
Librería: Biblios, Frankfurt am main, HESSE, Alemania
EUR 133,88
Cantidad disponible: 3 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por Elsevier Science Publishing Co Inc, 2018
ISBN 10: 0128126264 ISBN 13: 9780128126264
Librería: THE SAINT BOOKSTORE, Southport, Reino Unido
EUR 126,83
Cantidad disponible: Más de 20 disponibles
Añadir al carritoHardback. Condición: New. New copy - Usually dispatched within 4 working days.
Librería: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 100,13
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: new. Questo è un articolo print on demand.
Idioma: Inglés
Publicado por Elsevier Science Dez 2018, 2018
ISBN 10: 0128126264 ISBN 13: 9780128126264
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
EUR 110,00
Cantidad disponible: 2 disponibles
Añadir al carritoBuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Pharmacogenomics: Challenges and Opportunities in Therapeutic Implementation, Second Edition, provides comprehensive coverage of the challenges and opportunities facing the therapeutic implications of pharmacogenomics from academic, regulatory, pharmaceutical, socio-ethical and economic perspectives. While emphasis is on the limitations in moving the science into drug development and direct therapeutic applications, this book also focuses on clinical areas with successful applications and important initiatives that have the ability to further advance the discipline. New chapters cover important topics such as pharmacogenomic data technologies, clinical testing strategies, cost-effectiveness, and pharmacogenomic education and practice guidelines. The importance of ethnicity is also discussed, which highlights phar,acogenomic diversity across Latin American populations.With chapters written by interdisciplinary experts and insights into the future direction of the field, this book is an indispensable resource for academic and industry scientists, graduate students and clinicians engaged in pharmacogenomics research and therapeutic implementation. 442 pp. Englisch.
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 117,88
Cantidad disponible: 2 disponibles
Añadir al carritoBuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Pharmacogenomics: Challenges and Opportunities in Therapeutic Implementation, Second Edition, provides comprehensive coverage of the challenges and opportunities facing the therapeutic implications of pharmacogenomics from academic, regulatory, pharmaceutical, socio-ethical and economic perspectives. While emphasis is on the limitations in moving the science into drug development and direct therapeutic applications, this book also focuses on clinical areas with successful applications and important initiatives that have the ability to further advance the discipline. New chapters cover important topics such as pharmacogenomic data technologies, clinical testing strategies, cost-effectiveness, and pharmacogenomic education and practice guidelines. The importance of ethnicity is also discussed, which highlights phar,acogenomic diversity across Latin American populations.With chapters written by interdisciplinary experts and insights into the future direction of the field, this book is an indispensable resource for academic and industry scientists, graduate students and clinicians engaged in pharmacogenomics research and therapeutic implementation.